XinThera, a company focused on building a small molecule oncology and immunology pipeline, announced today that the company has raised $50M in Series B financing.
San Francisco based-Nurix has closed its funding round with a total of $120m. The financing was led by Foresite Capital and supported by new investors Bain Capital Life Sciences ...